DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» 3F8
3F8
Patient Resource Free
Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
The Two Tontti Tudiul Lui Hi Ha Unit
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
(12) Patent Application Publication (10) Pub. No.: US 2015/0250896 A1 Zhao (43) Pub
A Primer on Humoral Immunity and Antibody Constructs for The
(Dfmo) & Etoposide Loaded Nanocarriers for the Tr
Implications of the 2017 Fda Reauthorization Act on Pediatric Cancer Drug Development: an Industry Perspective
Patent Application Publication Oo) Pub. No.: US 2015/0284416 Al Zhao (43) Pub
Optimized Fc Variants
Paul Sondel MD Phd University of Wisconsin Madison Antibody Therapy
Mskcc Therapeutic/Diagnostic Protocol
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
2018 Medicines in Development for Cancer
3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid For
Ep 2739649 B1
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
Modulation of Interactions of Neuroblastoma Cell Lines With
Top View
Patent Application Publication Oo) Pub. No.: US 2015/0322155 Al Zhao (43) Pub
August 17, 2021 George Sgouros, Ph.D. [Date of This Version]
RIT): Moving Forward Jordan M
Wo 2010/095940 A2
LTR-16-0131 Hossein Jadvar, President, Society of Nuclear
Assessment of the Evolution of Cancer Treatment Therapies
Understanding Cancer Immunotherapy
Antibody-Drug Conjugate (Adc) and Method for Forming the Same
Antibody Therapy of Cancer
New Agents, Emerging Late Effects, and the Development of Precision Survivorship Eric J
Immunogenicity of the Hu14.18-IL2 Immunocytokine Molecule in Adults with Melanoma and Children with Neuroblastoma Jacquelyn A
Humanized-3F8
Novel Therapies for Relapsed and Refractory Neuroblastoma
(12) United States Patent (10) Patent No.: US 9,345,770 B2 Storkus Et Al
Colorado Cancer Coalition and Task Force Updates
International Journal of Current Advanced Research
Radioimmunotherapy of Human Tumours
Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
Anti-Alphavbeta3 Monoclonal Antibody EMD 525797 (CUI C2830088) Add to Cart
Study Protocols Should Detail the Conditions Under Which Such Lesions Would Be Considered Measurable
Out Like a Lion: Marching CAR-T Cells Towards Enhanced Efficacy in ALL
Radioimmunodetection of Neuroblastoma with Iodine- 13 1-.3F8
Targeting Human Cancer Stem Cells with Monoclonal Antibodies
Assessment of the Evolution of Cancer Treatment Therapies
Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing with Granulocyte
Us 2019 / 0127401 A1
In Murine Tumor Models Antibodies Activity of Antitumor Monoclonal
Amendment Protocol Number: 09C0025-O Reference Number: 347293
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al
Human BMPR1B Amino Acid Sequence
Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging
Localization of GD2-Specificmonoclonal Antibody 3F8 in Human Osteosarcoma1
Antibody-Based Targeted Radiation to Pediatric Tumors